• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: PD

ECG abnormalities may be PD risk factor

July 6, 2011  

First report of increased risk of prostate cancer in PD

June 29, 2011  

NMDA antagonists in Parkinson’s disease: meta-analysis

June 29, 2011  

Deep brain stimulation: consensus recommendations

March 9, 2011  

MoCA recommended to detect cognitive dysfunction in Parkinson’s disease

February 23, 2011  

Parkinson’s disease and melanoma: no genetic link

February 9, 2011  

Trial of pramipexole for depression in PD

December 8, 2010  

SCT in Parkinson’s disease

September 15, 2010  

Treatment of nonmotor symptoms: AAN report

September 1, 2010  

Trichloroethylene associated with PD risk

July 7, 2010  
Previous
3
4
5
6
7
Next

Browse by Topic

  • MS (439)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Beyond remission: redefining the goal of schizophrenia management posted on August 4, 2015
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Management of refractory epilepsy: highlights from ILAE 2025 posted on October 29, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions